Core Viewpoint - A securities class action lawsuit has been filed against MicroStrategy Incorporated, alleging that the company made materially false and misleading statements regarding its business and operations during the specified Class Period from April 30, 2024, to April 4, 2025 [1][2]. Group 1: Allegations Against MicroStrategy - The lawsuit claims that the anticipated profitability of MicroStrategy's bitcoin-focused investment strategy was overstated [2]. - It is alleged that the risks associated with bitcoin's volatility and potential losses on digital assets were understated [2]. - The complaint asserts that the public statements made by the defendants were materially false and misleading throughout the Class Period [2]. Group 2: Lead Plaintiff Process - Investors in MicroStrategy have until July 15, 2025, to seek appointment as a lead plaintiff representative of the class [3]. - A lead plaintiff acts on behalf of all class members and is typically the investor or group of investors with the largest financial interest [3]. - The lead plaintiff has the authority to select counsel to represent the class, subject to court approval [3]. Group 3: Law Firm Information - Kessler Topaz Meltzer & Check, LLP is encouraging investors who have suffered losses to contact them for more information [4]. - The firm has a reputation for prosecuting class actions and has recovered billions for victims of corporate misconduct [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fortrea Holdings, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on August 1, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - Investors who bought Fortrea securities between July 3, 2023, and February 28, 2025, may be eligible to join a class action lawsuit [1][2]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline [2]. - The lawsuit alleges that Fortrea made false and misleading statements regarding its revenue projections and cost savings, which inflated its EBITDA targets for 2025 [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen has been recognized as a Titan of Plaintiffs' Bar by Law360, highlighting the firm's expertise in this area [3].

To join the Reddit class action, go to https://rosenlegal.com/submit-form/?case_id=40507 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead p ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important July 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Elevance common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Elevance clas ...

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”). The Complaint alleges that Defendants created the false impression that ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Centene between December 12, 2024 and June 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Faruqi & ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Apple Inc. securities between June 10, 2024, and June 9, 2025, about the upcoming lead plaintiff deadline on August 19, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Apple securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by August 19, 2025 [2]. - The lawsuit alleges that Apple made false and misleading statements regarding the integration of advanced AI-based Siri features, which impacted the expected sales of the iPhone 16 [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Rosen Law Firm has been recognized for its performance in securities class action settlements, being ranked No. 1 in 2017 and consistently in the top 4 since 2013 [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of 3D Systems Corporation during the specified Class Period of the upcoming lead plaintiff deadline on August 12, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought 3D Systems securities between August 13, 2024, and May 12, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by August 12, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, 3D Systems made false and misleading statements regarding the impact of weakened customer spending and overstated its resilience in challenging industry conditions [4]. - It is claimed that the updated milestone criteria in a partnership with United Therapeutics Corporation would negatively affect 3D Systems' Regenerative Medicine Program revenue, leading to materially false public statements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Sarepta Therapeutics, Inc. during the specified class period of the upcoming lead plaintiff deadline on August 25, 2025 [1] Group 1: Class Action Details - Investors who purchased Sarepta securities between June 22, 2023, and June 24, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by August 25, 2025 [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting their own achievements in this area [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] - Rosen Law Firm has been recognized for its performance in securities class action settlements, being ranked No. 1 in 2017 and consistently in the top 4 since 2013 [4] Group 3: Case Specifics - The lawsuit alleges that Sarepta made false and misleading statements regarding the safety and efficacy of its gene therapy, ELEVIDYS, which is intended for treating Duchenne muscular dystrophy [5] - Key issues raised include significant safety risks associated with ELEVIDYS, failure to detect severe side effects in trials, and the potential for regulatory scrutiny due to adverse events [5] - The lawsuit claims that these misrepresentations led to investor damages when the true information became public [5]

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of iRobot Corporation securities purchasers during the specified Class Period, indicating potential legal issues for the company [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to securities purchased between January 29, 2024, and March 11, 2025, and aims to address misleading statements made by iRobot regarding its financial stability and restructuring plans [1][5]. - The lawsuit claims that iRobot overstated the effectiveness of its Restructuring Plan following the termination of the Amazon Acquisition, leading to doubts about its ability to operate profitably as a standalone entity [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees, as compensation may be available through a contingency fee arrangement [2][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering substantial amounts for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, achieving significant recoveries, including over $438 million in 2019 alone [4]. Group 3: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the firm directly for more information [3][6]. - It is noted that no class has been certified yet, and investors may choose to remain absent or select their own counsel [7].